JP Morgan Initiates Coverage On Trex Bio with Overweight Rating, Announces Price Target of $20
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsInitiationPrice Target
JP Morgan analyst Brian Cheng initiates coverage on Trex Bio (NASDAQ:TRXB) with a Overweight rating and announces Price Target of $20.
JP Morgan analyst Brian Cheng initiates coverage on Trex Bio (NASDAQ:TRXB) with a Overweight rating and announces Price Target of $20.